BioInvent International AB is a clinical-stage biotech company that discovers and develops novel and immuno-modulatory antibodies for cancer therapy. The company is headquartered in Lund, Skane and currently employs 122 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.
Follow-Up Questions
BOVNF 股票的价格表现如何？
BOVNF 的当前价格为 $0，在上个交易日 decreased 了 0%。
BioInvent International AB 的主要业务主题或行业是什么？
BioInvent International AB 属于 Biotechnology 行业，该板块是 Health Care
BioInvent International AB 的市值是多少？
BioInvent International AB 的当前市值是 $0
BioInvent International AB 是买入、卖出还是持有？
据华尔街分析师称，共有 5 位分析师对 BioInvent International AB 进行了分析师评级，包括 3 位强烈买入，5 位买入，1 位持有，0 位卖出，以及 3 位强烈卖出
